Achieve Life Sciences, Inc. (ACHV) stock
ACHVNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as QUIT
$6.72+0.34 (+5.33%)
Close on Nov 6, 2026Market cap $691.50MP/E –Yield –
Achieve Life Sciences market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Achieve Life Sciences's market cap was $690.26M on Nov 6, 2026, against $257.20M a year earlier. Over the last 5 years it ranged from $21.40M to $830.98M, with a median of $111.17M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 6, 2026 | $690.26M | +163.0% |
| 2025 | Dec 31, 2025 | $262.48M | +116.8% |
| 2024 | Dec 31, 2024 | $121.05M | +38.8% |
| 2023 | Dec 29, 2023 | $87.20M | +266.5% |
| 2022 | Dec 30, 2022 | $23.79M | -67.7% |
| 2021 | Dec 31, 2021 | $73.55M | +151.1% |
| 2020 | Dec 31, 2020 | $29.29M | -65.9% |
| 2019 | Dec 31, 2019 | $85.89M | -27.6% |
| 2018 | Dec 31, 2018 | $118.61M | -96.1% |
| 2017 | Dec 29, 2017 | $3.08B | +13040.0% |
| 2016 | Dec 30, 2016 | $23.42M | -58.4% |
| 2015 | Dec 31, 2015 | $56.26M | -26.0% |
| 2014 | Dec 31, 2014 | $76.04M | -60.3% |
| 2013 | Dec 31, 2013 | $191.37M | -36.2% |
| 2012 | Dec 31, 2012 | $300.04M | +68.0% |
| 2011 | Dec 30, 2011 | $178.57M | – |
See a number that looks wrong?